MedPath

Development of TDM-guided treatment with daptomycin based on PK/PD theory by measurement of plasma concentration of daptomycin.

Not Applicable
Recruiting
Conditions
Patients with infection by Methicillin resistant Gram-positive cocci.
Registration Number
JPRN-UMIN000012015
Lead Sponsor
Infection control team of Osaka Medical College Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We analyze outcome and side effects of patients treated with daptomycin.
Secondary Outcome Measures
NameTimeMethod
We analyze relationship between plasma daptomycin concentration trough and creatine phosphokinase.
© Copyright 2025. All Rights Reserved by MedPath